Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuldeep K Roy

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
International Journal of Antimicrobial Agents|July 3, 2017
Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challengesKuldeep K Roy
Journal of Biomolecular Structure & Dynamics|June 23, 2021
Structural basis for the binding of a selective inverse agonist AF64394 with the human G-protein coupled receptor 3 (GPR3)Bharathi, Kuldeep K Roy
Current Drug Targets|December 28, 2023
ClpP Peptidase as a Plausible Target for the Discovery of Novel AntibioticsSmriti Bhardwaj, Kuldeep K Roy
Archives of Biochemistry and Biophysics|December 22, 2024
Decoding KRAS dynamics: Exploring the impact of mutations and inhibitor bindingDivya Pandey, Kuldeep K Roy
Journal of Biomolecular Structure & Dynamics|January 9, 2026
Elucidating the structural basis of ClpP activation and dynamics in <i>Mycobacterium tuberculosis</i>Smriti Bhardwaj, Kuldeep K Roy
Journal of Biomolecular Structure & Dynamics|December 19, 2023
Deciphering insights into the binding mechanism and plasticity of Telacebec with <i>M. tuberculosis</i> cytochrome <i>bcc-aa3</i> supercomplex through an unbiased molecular dynamics simulation, free-energy analysis, and DFT studyBedabrata Ray, Kuldeep K Roy
Expert Opinion on Drug Discovery|November 28, 2019
Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discoveryKuldeep K Roy, Mushtaq Ahmad Wani
Molecular Diversity|June 10, 2021
Development and validation of consensus machine learning-based models for the prediction of novel small molecules as potential anti-tubercular agentsMushtaq Ahmad Wani, Kuldeep K Roy
Journal of Chemical Information and Modeling|May 4, 2011
Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonistsKuldeep K Roy, Anil K Saxena
ACS Chemical Neuroscience|February 12, 2026
BDNF- Dysregulation as a Neurobiological Bridge between Polycystic Ovarian Syndrome and Autism Spectrum DisorderHimani Nautiyal, Kuldeep K Roy, Shubham Dwivedi
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Antimicrobial Agents|July 3, 2017
Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challengesKuldeep K Roy
Journal of Biomolecular Structure & Dynamics|June 23, 2021
Structural basis for the binding of a selective inverse agonist AF64394 with the human G-protein coupled receptor 3 (GPR3)Bharathi, Kuldeep K Roy
Current Drug Targets|December 28, 2023
ClpP Peptidase as a Plausible Target for the Discovery of Novel AntibioticsSmriti Bhardwaj, Kuldeep K Roy
Archives of Biochemistry and Biophysics|December 22, 2024
Decoding KRAS dynamics: Exploring the impact of mutations and inhibitor bindingDivya Pandey, Kuldeep K Roy
Journal of Biomolecular Structure & Dynamics|January 9, 2026
Elucidating the structural basis of ClpP activation and dynamics in <i>Mycobacterium tuberculosis</i>Smriti Bhardwaj, Kuldeep K Roy
Journal of Biomolecular Structure & Dynamics|December 19, 2023
Deciphering insights into the binding mechanism and plasticity of Telacebec with <i>M. tuberculosis</i> cytochrome <i>bcc-aa3</i> supercomplex through an unbiased molecular dynamics simulation, free-energy analysis, and DFT studyBedabrata Ray, Kuldeep K Roy
Expert Opinion on Drug Discovery|November 28, 2019
Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discoveryKuldeep K Roy, Mushtaq Ahmad Wani
Molecular Diversity|June 10, 2021
Development and validation of consensus machine learning-based models for the prediction of novel small molecules as potential anti-tubercular agentsMushtaq Ahmad Wani, Kuldeep K Roy
Journal of Chemical Information and Modeling|May 4, 2011
Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonistsKuldeep K Roy, Anil K Saxena
ACS Chemical Neuroscience|February 12, 2026
BDNF- Dysregulation as a Neurobiological Bridge between Polycystic Ovarian Syndrome and Autism Spectrum DisorderHimani Nautiyal, Kuldeep K Roy, Shubham Dwivedi
Pageof 5